ESTRO 38 Abstract book

S1217 ESTRO 38

1. Collaborative model of care and engagement between Oncologists, CNC and the treating team to optimise patient outcomes. 2. Patients were able to be identified earlier in the pathway, with a radiotherapy care plan initiated immediately post MDTM. 3. Inpatient nursing reviews identified patient care needs which were incorporated into the treatment pathway. 4. Toxicity management was assessed and initiated by the CNC who collaborated with inpatient clinicians, influencing earlier discharge. 5. Coordination of multimodality treatment and providing education to patients, carers and MDT members and other relevant stakeholders. 6. Minimising the administrative responsibility and burden on the Medical/Radiation Oncologists guides the appropriate skillset utilisation of all members of the MDT. and efficiently manages the process requirements associated with treatment initiation. 7. Tumour specific initiatives such as a Head & Neck Allied Health MDTM were established to able the MDT to collaboratively manage toxicities and patient supportive measures. NPS improved from 67% to 100%. Conclusion The study indicated that the RT CNC demonstrated significant efficiencies, in reducing diagnosis to treatment start time through a collaborative and coordinated approach. The results suggest that the CNC plays a key role in providing clinical expertise, establishing and embedding external relationships and integration within a large tertiary hospital. After the pilot evaluation the CNC role has been implemented at other affiliated institutions. Further investigation will continue evaluating metrics on all aspects of the inpatient oncology service. EP-2209 Non-medical prescribing for Therapeutic Radiographers – extending roles and advancing practice H. Nisbet 1 1 Oxford University Hospitals NHS Foundation Trust, Radiotherapy Department, Oxford, United Kingdom Purpose or Objective Legislation has been in place in the UK to allow Therapeutic Radiographers to train as supplementary prescribers (SP) and the role has been successfully undertaken since 2005. Since March 2016 Therapeutic Radiographers can train as independent prescribers and this has been supported by the Royal College of Radiologists citing a positive patient experience, a more streamlined patient pathway and a sharing of the pressures of the clinical team’s workload as just some of the very substantial benefits. One Advanced and two Consultant Therapeutic Radiographers at our Cancer Centre completed their qualification to become independent prescribers (IP) in June 2017. The objective of this poster is to outline the training pathway, scope of practice and clinical model for Therapeutic Radiographer non-medical prescribers (NMP) and to detail the advantages of this role. Material and Methods The NMP must undergo an approved post-registration training programme that meets the prescribing standards set by the Health Professions Council before being annotated as an IP/SP on the register in order to be able to prescribe. As with most Trusts, the NMP must also be accepted into the role by the Trust's NMP lead for indemnity purposes. They may prescribe any licensed medicine for any condition within national and local Electronic Poster: RTT track: Education and training/role development

Material and Methods A prostate prospective clinical trial required all participants to have prostate FMs. All participants were invited to complete a simple questionnaire designed to capture their experience of FM insertion and any side effects they experienced within 1 week of implantation. FM insertion was performed trans-perineally under TRUS guidance using local anaesthetic and antibiotic prophylaxis. Results 58 participants were each implanted with three gold FMs, verified on CT planning scan . A total of 56 out of 58 (97%) questionnaires were returned. An overall summary of patient reported symptoms following FM implantation are given in Figure 1.

Conclusion In our centre, FM insertion is well tolerated. Acute side effects were mild to moderate and in general were transient, resolving within a few days. Grade >3 toxicity was rare and self-managed with the use of simple analgesics. Efforts to standardise patient preparation, implantation procedures and data collection to allow meaningful comparison and inform best practice are needed. EP-2208 Evaluating the efficacy of the Cancer Nurse Consultant Role for Radiotherapy Oncology inpatients M. Rolfo 1 , T. Pearce 2 , J. Armstrong 3 , M. Guiney 4 , S. Ryan 3 1 Genesiscare UK, Radiation Oncology, Berkshire, United Kingdom; 2 GenesisCareUnited Kingdom, Radiation Oncology Berkshire, United Kingdom; 3 GenesiCare Australia, Radiation Oncology, Melbourne, Australia; 4 GenesisCare Australia, Radiation Oncology, Melbourne, Australia Purpose or Objective A pilot study to validate the implementation of a Cancer Nurse Consultant (CNC) role in a busy tertiary cancer centre in improving the patient experience, providing clinical expertise and coordinating all aspects in relation to the delivery of radiotherapy treatment to inpatients. Material and Methods This pilot study was conducted in 2017 in a major tertiary hospital with over 800 inpatient beds and a comprehensive oncology program covering many tumour streams. In this evaluation, the CNC participated in the Multi-Disciplinary Team Meetings (MDTM) to initiate timely interventions and proactively manage the continuum of care for inpatients undergoing radiotherapy (RT). Participation of the CNC in MDTMs was postulated to enable better coordination and implementation of earlier interventions and create a efficient pathway for the patient to access care. Inpatients satisfaction termed a Net Promoter Score (NPS) metrics were taken Results The evaluation demonstrated that the CNC was able to intervene earlier in the patient pathway and ensure that the time from MDT to treatment initiation was reduced byan average of 2 days. Findings included: